Personalis, Inc. Logo

Personalis, Inc.

Offers advanced cancer genomics and data analysis for personalized therapies.

PSNL | US

Overview

Corporate Details

ISIN(s):
US71535D1063
LEI:
Country:
United States of America
Address:
6600 DUMBARTON CIRCLE, 94555 FREMONT

Description

Personalis, Inc. is a company specializing in advanced cancer genomics that provides sequencing and data analysis solutions to transform the active management of cancer. The company's core technology is the NeXT Platform, which supports a suite of advanced genomic tests. Key offerings include NeXT Personal®, an ultra-sensitive, personalized liquid biopsy test for detecting molecular residual disease (MRD) and cancer recurrence earlier than standard imaging. The company also offers NeXT Dx™, a comprehensive tumor profiling service that analyzes the exome to help guide targeted therapy decisions. For its biopharmaceutical partners, Personalis provides the ImmunoID NeXT® platform, a biomarker analysis tool that supports the development of personalized cancer therapies and vaccines. By combining deep genomic sequencing with advanced analytics, Personalis aims to provide critical insights for clinicians and researchers to enable personalized treatment strategies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Personalis, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Personalis, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Personalis, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

biote Corp. Logo
A practice-building business focused on bioidentical hormone replacement therapy.
United States of America
BTMD
BML, INC. Logo
Provider of laboratory testing services and medical information systems.
Japan
4694
BrightSpring Health Services, Inc. Logo
Provider of home and community-based health and pharmacy services for complex populations.
United States of America
BTSG
CareDx, Inc. Logo
Develops diagnostic solutions and genomics-based tests for organ transplant patients.
United States of America
CDNA
Caris Life Sciences, Inc. Logo
Biotechnology firm using molecular science and AI for precision cancer care.
United States of America
CAI
CASTLE BIOSCIENCES INC Logo
A diagnostics company developing molecular tests for dermatologic cancers.
United States of America
CSTL
CellSource Co.,Ltd. Logo
Provides cell and tissue processing services for regenerative medicine.
Japan
4880
CHEMED CORP Logo
Operates subsidiaries in hospice care and plumbing and drain cleaning services.
United States of America
CHE
Concentra Group Holdings Parent, Inc. Logo
Provider of occupational health services for the workforce via a national clinic network.
United States of America
CON
Constance Care Spolka Akcyjna W Restrukturyzacji Logo
Medical center for neurological rehabilitation using manual and robotic therapies.
Poland
CCR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.